These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Inflammasome--essential regulator of the inflammatory reaction]. Junttila I; Meri S; Rämet M Duodecim; 2013; 129(7):705-11. PubMed ID: 23720939 [TBL] [Abstract][Full Text] [Related]
6. Inflammasome activation in response to dead cells and their metabolites. Kono H; Kimura Y; Latz E Curr Opin Immunol; 2014 Oct; 30():91-8. PubMed ID: 25282339 [TBL] [Abstract][Full Text] [Related]
7. A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation? Wen H; Ting JP; O'Neill LA Nat Immunol; 2012 Mar; 13(4):352-7. PubMed ID: 22430788 [TBL] [Abstract][Full Text] [Related]
9. The inflammasome in atherosclerosis and type 2 diabetes. Masters SL; Latz E; O'Neill LA Sci Transl Med; 2011 May; 3(81):81ps17. PubMed ID: 21543720 [TBL] [Abstract][Full Text] [Related]
10. Innate immune receptors: key regulators of metabolic disease progression. Jin C; Henao-Mejia J; Flavell RA Cell Metab; 2013 Jun; 17(6):873-882. PubMed ID: 23747246 [TBL] [Abstract][Full Text] [Related]
11. Damage-associated molecular patterns and their pathological relevance in diabetes mellitus. Shin JJ; Lee EK; Park TJ; Kim W Ageing Res Rev; 2015 Nov; 24(Pt A):66-76. PubMed ID: 26197086 [TBL] [Abstract][Full Text] [Related]
12. NLRP3 inflammasomes link inflammation and metabolic disease. De Nardo D; Latz E Trends Immunol; 2011 Aug; 32(8):373-9. PubMed ID: 21733753 [TBL] [Abstract][Full Text] [Related]
13. Recent insights on modulation of inflammasomes by adipokines: a critical event for the pathogenesis of obesity and metabolism-associated diseases. Pham DV; Park PH Arch Pharm Res; 2020 Oct; 43(10):997-1016. PubMed ID: 33078304 [TBL] [Abstract][Full Text] [Related]
15. Inflammasome Signaling and Other Factors Implicated in Atherosclerosis Development and Progression. Nazarian-Samani Z; Sewell RDE; Rafieian-Kopaei M Curr Pharm Des; 2020; 26(22):2583-2590. PubMed ID: 32364068 [TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes. Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H Front Immunol; 2020; 11():571731. PubMed ID: 33178196 [TBL] [Abstract][Full Text] [Related]
18. Inflammasomes. de Zoete MR; Palm NW; Zhu S; Flavell RA Cold Spring Harb Perspect Biol; 2014 Oct; 6(12):a016287. PubMed ID: 25324215 [TBL] [Abstract][Full Text] [Related]
19. Pacific Populations, Metabolic Disease and 'Just-So Stories': A Critique of the 'Thrifty Genotype' Hypothesis in Oceania. Gosling AL; Buckley HR; Matisoo-Smith E; Merriman TR Ann Hum Genet; 2015 Nov; 79(6):470-80. PubMed ID: 26420513 [TBL] [Abstract][Full Text] [Related]
20. Inflammasome as a New Therapeutic Target for Diabetic Complications. Volpe CM; Anjos PM; Nogueira-Machado JA Recent Pat Endocr Metab Immune Drug Discov; 2016; 10(1):56-62. PubMed ID: 26899852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]